Cresco Labs Inc.’s US$213 Million Proposed Acquisition Of Bluma Wellness Inc.

Gowling WLG advised Bluma on the transaction.

Bluma Wellness Inc. (CSE: BWEL.U) (OTCQX: BMWLF) (“Bluma”) announced that it had entered into a definitive agreement with Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Bluma in an all-share transaction that values Bluma at an equity value of US$213 million. The transaction will be completed by way of plan of arrangement under the Business Corporations Act(British Columbia).

Gowling WLG (Canada) LLP is advising Bluma on the transaction, with a multi-disciplinary team comprised of members from the firm’s corporate, securities, competition, tax and advocacy practices and led by Peter Simeon (Picture), co-leader of Gowling WLG’s Cannabis Group.

Involved fees earner: Peter Simeon – Gowling WLG;

Law Firms: Gowling WLG;

Clients: Bluma Wellness;


Author: Ambrogio Visconti